AGEN

Agenus (AGEN)

About Agenus (AGEN)

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.

Details

Daily high

$4.00

Daily low

$3.01

Price at open

$3.50

52 Week High

$7.34

52 Week Low

$1.38

Market cap

117.0M

Dividend yield

0.00%

Volume

6,665

Avg. volume

599,897

P/E ratio

-1.62

Agenus News